Cambrex Corp. (CBM) Misses Q3 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. JBLU
2. META
3. SSD
4. AVGO
5. CDNS
6. PECO
7. AGYS
8. HWKN
9. INTC
10. RMBS

Go back to Cambrex Corp. (CBM) Misses Q3 EPS by 8c

Cambrex Reports Third Quarter 2018 Financial Results

November 8, 2018 6:40 AM EST

- Acquired Halo Pharma, broadening capabilities, enhancing revenue growth and expanding customer base -

- Conference call at 8:30 a.m. ET on November 8, 2018 -

EAST RUTHERFORD, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, reports results for the third quarter ended September 30, 2018.

Third Quarter 2018 Highlights

Completed the acquisition of Halo Pharma (Halo), a leading finished dosage form Contract Development and... More